PUBLISHER: The Business Research Company | PRODUCT CODE: 1664757
PUBLISHER: The Business Research Company | PRODUCT CODE: 1664757
Thrombophilia Global Market Report 2025
Thrombophilia denotes a blood condition heightening the likelihood of clot formation within veins and arteries, potentially stemming from arterial or venous clotting or a hereditary (genetic) or acquired predisposition. This condition bears the potential to trigger severe health complications such as heart attacks, strokes, kidney failure, and pulmonary embolisms.
The primary thrombophilia types encompass factor V Leiden, prothrombin 20210, antiphospholipid syndrome, among others. Factor V Leiden involves a mutation in one of the blood-clotting factors. Treatment options include medications such as Heparin, Warfarin, and others, administered through various routes including oral and parenteral. End-users of these treatments span across hospitals, home health agencies, specialty centers, and similar entities.
The thrombophilia market research report is one of a series of new reports from. The Business Research Company that provides thrombophilia market statistics, including thrombophilia industry global market size, regional shares, competitors with a thrombophilia market share, detailed thrombophilia market segments, market trends and opportunities, and any further data you may need to thrive in the thrombophilia industry. This thrombophilia market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The thrombophilia market size has grown strongly in recent years. It will grow from $17.03 billion in 2024 to $18.35 billion in 2025 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to increasing awareness, research and development in anticoagulant therapies, aging population, genetic research, increased incidence of thrombotic disorders.
The thrombophilia market size is expected to see strong growth in the next few years. It will grow to $25.12 billion in 2029 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to personalized medicine, emergence of novel therapies, integration of artificial intelligence, healthcare policy and regulation, increased patient education and empowerment. Major trends in the forecast period include technological advancements, expanded role of telemedicine, rising incidence rates, biopharmaceutical developments, collaborative research initiatives.
The growing elderly population is expected to drive the expansion of the thrombophilia market in the future. The elderly population consists of individuals aged 65 and older, with the proportion of the dependent population calculated as the total elderly and youth population in relation to the overall population. Thrombophilic risk factors are prevalent among older adults, enabling the identification of a population at risk for poor clinical outcomes. As a result, the increasing elderly population will boost demand for thrombophilia drugs. For example, according to data from America's Health Rankings, a U.S.-based organization that evaluates health outcomes, in 2022, over 56 million adults aged 65 and older made up approximately 16.9% of the total U.S. population. This number is projected to rise to more than 73.1 million by 2030. Therefore, the increase in the elderly population is fueling the growth of the thrombophilia market.
The increasing prevalence of thrombophilic conditions is anticipated to contribute significantly to the growth of the thrombophilia market in the years ahead. Thrombophilic diseases, characterized by an elevated predisposition to blood clot formation (thrombosis), play a crucial role in shaping the thrombophilia market landscape, influencing diagnosis, treatment approaches, and ongoing research. For example, in August 2023, data from the Nuffield Trust revealed that the UK had the highest number of cases of Deep Vein Thrombosis (DVT) among eight nations providing data. In 2021, there were 352 cases, increasing to 377 for every 100,000 hospital discharges in 2022. This surge in the prevalence of thrombophilic conditions serves as a key factor driving the thrombophilia market.
Technological advancements are emerging as a key trend gaining traction in the thrombophilia market. Leading companies in the market are focusing on developing innovative technologies to maintain their competitive edge. For example, in May 2023, researchers at the University of California, San Diego, developed a revolutionary technology called Eloctate, which has the potential to transform hemophilia treatment. This cutting-edge approach uses a novel fusion protein that significantly improves the stability and half-life of coagulation factors in the bloodstream. By integrating this technology with existing therapies, the researchers aim to create long-acting drugs that require less frequent dosing, enhancing patient compliance and overall quality of life.
Major companies in the thrombophilia market are strategically pursuing partnerships to advance the development of biosynthetic heparin. Strategic partnerships involve leveraging each other's strengths and resources for mutual benefits and success. For example, in January 2022, Optimvia, LLC, a US-based biotechnology company, announced a partnership with Ginkgo Bioworks with the aim of enhancing the efficiency of biosynthetic heparin synthesis. Optimvia plans to utilize Ginkgo's cell and enzyme engineering systems, along with its fermentation manufacturing capabilities, to expedite the improvement of its biosynthetic heparin production method. The collaboration aims to create commercially viable, cost-effective, and safe biosynthetic heparin, potentially reducing the global dependence on heparin sourced from livestock. Ginkgo Bioworks, a US-based company specializing in cell programming, provides a platform to support this innovative partnership in the thrombophilia market.
In March 2022, Pfizer Inc., a prominent US-based pharmaceutical company, successfully completed the acquisition of Arena Pharmaceuticals for a substantial sum of $6.7 billion. As a result of this acquisition, Arena Pharmaceuticals has now become a subsidiary of Pfizer. This strategic move is anticipated to foster innovations aimed at enhancing the lives of individuals grappling with immuno-inflammatory disorders. Arena Pharmaceuticals, Inc., the acquired entity, is based in the United States and is dedicated to developing treatments for thromboembolic disorders affecting the arterial blood vessels. The acquisition reflects Pfizer's commitment to expanding its portfolio and capabilities in the field of pharmaceuticals, particularly in addressing disorders related to the immune and inflammatory systems.
Major companies operating in the thrombophilia market include Pfizer Inc., F. Hoffmann-La Roche Limited, Changzhaou Qianhong Bio-pharma Co. Limited, Fresenius Kabi AG, Hebei Changshan Biochemical Pharmaceutical Co. Limited, Hikma Pharmaceuticals PLC., Novartis AG, Shanghai Fosun Pharmaceutical (Group) Co. Ltd., Shenzhen Hepalink Pharmaceutical Group Co. Limited, Teva Pharmaceutical Industries Limited, Yino Pharma Limited, Sanofi SA, Eisai Co. Limited, Boehringer Ingelheim GmbH, Instrumentation Laboratory SpA, Johnson & Johnson, Laurus Lab, Bristol-Myers Squibb, Roche, Abbott, C. H. Boehringer Sohn, Portola Pharmaceuticals, Daiichi Sankyo, Bayer Group, GlaxoSmithKline plc, CSL Behring
North America was the largest region in the thrombophilia market in 2024. The regions covered in the thrombophilia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the thrombophilia market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The thrombophilia market consists of sales of rivaroxaban, apixaban, and thrombolytics. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Thrombophilia Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on thrombophilia market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for thrombophilia ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The thrombophilia market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Type: Factor V Leiden; Prothrombin 20210; Antiphospholipid Syndrome; Other Type
- 2) By Drugs: Heparin; Warfarin; Other Drugs
- 3) By Route Of Administration: Oral; Parenteral; Other Route Of Administration
- 4) By End-Users: Hospitals; Homecare; Specialty Centers; Other End Users
- Subsegments:
- 1) By Factor V Leiden: Genetic Testing; Anticoagulant Therapy
- 2) By Prothrombin 20210: Genetic Testing; Anticoagulant Therapy
- 3) By Antiphospholipid Syndrome: Antiphospholipid Antibody Testing; Anticoagulant Therapy
- 4) By Other Types: Protein C Deficiency; Protein S Deficiency; Antithrombin III Deficiency; Other Genetic Conditions
- Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche Limited; Changzhaou Qianhong Bio-pharma Co. Limited; Fresenius Kabi AG; Hebei Changshan Biochemical Pharmaceutical Co. Limited
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Thrombophilia Market Characteristics
3. Thrombophilia Market Trends And Strategies
4. Thrombophilia Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Thrombophilia Growth Analysis And Strategic Analysis Framework
- 5.1. Global Thrombophilia PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Thrombophilia Market Growth Rate Analysis
- 5.4. Global Thrombophilia Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Thrombophilia Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Thrombophilia Total Addressable Market (TAM)
6. Thrombophilia Market Segmentation
- 6.1. Global Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Factor V Leiden
- Prothrombin 20210
- Antiphospholipid Syndrome
- Other Type
- 6.2. Global Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Heparin
- Warfarin
- Other Drugs
- 6.3. Global Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Oral
- Parenteral
- Other Route Of Administration
- 6.4. Global Thrombophilia Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Homecare
- Speciality Centres
- Other End Users
- 6.5. Global Thrombophilia Market, Sub-Segmentation Of Factor V Leiden, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Genetic Testing
- Anticoagulant Therapy
- 6.6. Global Thrombophilia Market, Sub-Segmentation Of Prothrombin 20210, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Genetic Testing
- Anticoagulant Therapy
- 6.7. Global Thrombophilia Market, Sub-Segmentation Of Antiphospholipid Syndrome, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Antiphospholipid Antibody Testing
- Anticoagulant Therapy
- 6.8. Global Thrombophilia Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Protein C Deficiency
- Protein S Deficiency
- Antithrombin III Deficiency
- Other Genetic Conditions
7. Thrombophilia Market Regional And Country Analysis
- 7.1. Global Thrombophilia Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Thrombophilia Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Thrombophilia Market
- 8.1. Asia-Pacific Thrombophilia Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Thrombophilia Market
- 9.1. China Thrombophilia Market Overview
- 9.2. China Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Thrombophilia Market
- 10.1. India Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Thrombophilia Market
- 11.1. Japan Thrombophilia Market Overview
- 11.2. Japan Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Thrombophilia Market
- 12.1. Australia Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Thrombophilia Market
- 13.1. Indonesia Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Thrombophilia Market
- 14.1. South Korea Thrombophilia Market Overview
- 14.2. South Korea Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Thrombophilia Market
- 15.1. Western Europe Thrombophilia Market Overview
- 15.2. Western Europe Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Thrombophilia Market
- 16.1. UK Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Thrombophilia Market
- 17.1. Germany Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Thrombophilia Market
- 18.1. France Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Thrombophilia Market
- 19.1. Italy Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Thrombophilia Market
- 20.1. Spain Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Thrombophilia Market
- 21.1. Eastern Europe Thrombophilia Market Overview
- 21.2. Eastern Europe Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Thrombophilia Market
- 22.1. Russia Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Thrombophilia Market
- 23.1. North America Thrombophilia Market Overview
- 23.2. North America Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Thrombophilia Market
- 24.1. USA Thrombophilia Market Overview
- 24.2. USA Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Thrombophilia Market
- 25.1. Canada Thrombophilia Market Overview
- 25.2. Canada Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Thrombophilia Market
- 26.1. South America Thrombophilia Market Overview
- 26.2. South America Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Thrombophilia Market
- 27.1. Brazil Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Thrombophilia Market
- 28.1. Middle East Thrombophilia Market Overview
- 28.2. Middle East Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Thrombophilia Market
- 29.1. Africa Thrombophilia Market Overview
- 29.2. Africa Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Thrombophilia Market Competitive Landscape And Company Profiles
- 30.1. Thrombophilia Market Competitive Landscape
- 30.2. Thrombophilia Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. F. Hoffmann-La Roche Limited Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Changzhaou Qianhong Bio-pharma Co. Limited Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Fresenius Kabi AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Hebei Changshan Biochemical Pharmaceutical Co. Limited Overview, Products and Services, Strategy and Financial Analysis
31. Thrombophilia Market Other Major And Innovative Companies
- 31.1. Hikma Pharmaceuticals PLC.
- 31.2. Novartis AG
- 31.3. Shanghai Fosun Pharmaceutical (Group) Co. Ltd.
- 31.4. Shenzhen Hepalink Pharmaceutical Group Co. Limited
- 31.5. Teva Pharmaceutical Industries Limited
- 31.6. Yino Pharma Limited
- 31.7. Sanofi SA
- 31.8. Eisai Co. Limited
- 31.9. Boehringer Ingelheim GmbH
- 31.10. Instrumentation Laboratory SpA
- 31.11. Johnson & Johnson
- 31.12. Laurus Lab
- 31.13. Bristol-Myers Squibb
- 31.14. Roche
- 31.15. Abbott
32. Global Thrombophilia Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Thrombophilia Market
34. Recent Developments In The Thrombophilia Market
35. Thrombophilia Market High Potential Countries, Segments and Strategies
- 35.1 Thrombophilia Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Thrombophilia Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Thrombophilia Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
